Aakash Desai, Associate Professor at UAB O’Neal Cancer Center, shared on X:
“Stop CT at year 5?
Lung cancer survivors (JAMA Oncology): Target trial emulation (n=55,694).
- CT past 5 yrs: more LC events found, HR 1.28
- All-cause death 2.62 vs 4.33%/yr, HR 0.66
- Observational.
Title: Chest Computed Tomography Receipt Beyond 5 Years After Lung Cancer Diagnosis and Survival
Authors: Dong Woog Yoon, Danbee Kang, Byeong-Ho Jeong, Hea Lim Choi, Juwon Park, Sun Hwa Lee, Dong Wook Shin, Hong Kwan Kim

You can also read:
Aakash Desai: “Playing Chess With Cancer” in EGFRm NSCLC․
FDA Grants Accelerated Approval to Neladalkib for ALK Positive Lung Cancer.
FDA Withholds Ivonescimab Approval in EGFR-Mutant NSCLC: Why HARMONi’s PFS Benefit Was Not Enough.
